Minghui Duan
0000-0003-2130-6300
1 paper found
Refreshing results…
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single‐arm, open‐label, phase 2, multicenter study
Missing publications? Search for publications with a matching author name.